{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:10:12Z","timestamp":1794579012645,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05505-5","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:44:35Z","timestamp":1751528675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Vasopressin use across shock states: international insights from an international ESICM-endorsed survey: the PRESS Survey"],"prefix":"10.1186","volume":"29","author":[{"given":"Mathieu","family":"Jozwiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir L.","family":"Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu L. N. G.","family":"Malbrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Cardiovascular Dynamics section of the European Society of Intensive Care Medicine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"11","key":"5505_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"5","key":"5505_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D\u2019Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122\u20135.","journal-title":"Circulation"},{"issue":"6","key":"5505_CR3","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","volume":"31","author":"T Sharshar","year":"2003","unstructured":"Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med. 2003;31(6):1752\u20138.","journal-title":"Crit Care Med"},{"issue":"18","key":"5505_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA. 2018;319(18):1889\u2013900.","journal-title":"JAMA"},{"issue":"6","key":"5505_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","volume":"45","author":"M Nagendran","year":"2019","unstructured":"Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, et al. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med. 2019;45(6):844\u201355.","journal-title":"Intensive Care Med"},{"issue":"6","key":"5505_CR6","doi-asserted-by":"publisher","first-page":"R181","DOI":"10.1186\/cc8167","volume":"13","author":"MW Dunser","year":"2009","unstructured":"Dunser MW, Ruokonen E, Pettila V, Ulmer H, Torgersen C, Schmittinger CA, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13(6):R181.","journal-title":"Crit Care"},{"issue":"1","key":"5505_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","volume":"7","author":"T Auchet","year":"2017","unstructured":"Auchet T, Regnier MA, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017;7(1):43.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"5505_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.chest.2022.07.018","volume":"163","author":"R Sato","year":"2023","unstructured":"Sato R, Duggal A, Sacha GL, Rudoni MA, Yataco AC, Khanna AK, et al. The Relationship Between Norepinephrine Equivalent Dose of Vasopressors Within 24 Hours From the Onset of Septic Shock and In-Hospital Mortality Rate. Chest. 2023;163(1):148\u201351.","journal-title":"Chest"},{"issue":"4","key":"5505_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/SHK.0b013e318289376b","volume":"39","author":"CA Schmittinger","year":"2013","unstructured":"Schmittinger CA, Dunser MW, Torgersen C, Luckner G, Lorenz I, Schmid S, et al. Histologic pathologies of the myocardium in septic shock: a prospective observational study. Shock. 2013;39(4):329\u201335.","journal-title":"Shock"},{"issue":"3","key":"5505_CR10","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3): e34.","journal-title":"J Med Internet Res"},{"issue":"5","key":"5505_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00134-022-06652-x","volume":"48","author":"M Leone","year":"2022","unstructured":"Leone M, Goyer I, Levy B, Dunser MW, Asfar P, Jentzer JC. Dose of norepinephrine: the devil is in the details. Intensive Care Med. 2022;48(5):638\u201340.","journal-title":"Intensive Care Med"},{"issue":"2","key":"5505_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00134-021-06595-9","volume":"48","author":"J Bakker","year":"2022","unstructured":"Bakker J, Kattan E, Annane D, Castro R, Cecconi M, De Backer D, et al. Current practice and evolving concepts in septic shock resuscitation. Intensive Care Med. 2022;48(2):148\u201363.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5505_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","volume":"52","author":"PM Wieruszewski","year":"2024","unstructured":"Wieruszewski PM, Leone M, Kaas-Hansen BS, Dugar S, Legrand M, McKenzie CA, et al. Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force. Crit Care Med. 2024;52(4):521\u201330.","journal-title":"Crit Care Med"},{"issue":"4","key":"5505_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/liv.13252","volume":"37","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Kedarisetty CK, Vashishtha C, Saini D, Kumar S, Maiwall R, et al. A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock. Liver Int. 2017;37(4):552\u201361.","journal-title":"Liver Int"},{"issue":"3","key":"5505_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102494","volume":"15","author":"T Gupta","year":"2025","unstructured":"Gupta T, Saini A, Gaur V, Goel A. Comparative Study of Terlipressin and Noradrenaline as Vasopressors in Patients With Acute-on-chronic Liver Failure and Septic Shock: A Randomized Controlled Trial. J Clin Exp Hepatol. 2025;15(3): 102494.","journal-title":"J Clin Exp Hepatol"},{"key":"5505_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2025.155038","volume":"87","author":"J Skvarce","year":"2025","unstructured":"Skvarce J, Bui A, Oro P, Sachar S, Harnegie MP, Kapoor A, et al. Multisystem hemodynamic effects of terlipressin in cirrhosis: A scoping review. J Crit Care. 2025;87: 155038.","journal-title":"J Crit Care"},{"issue":"1","key":"5505_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13613-018-0449-8","volume":"8","author":"O Lesur","year":"2018","unstructured":"Lesur O, Delile E, Asfar P, Radermacher P. Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions. Ann Intensive Care. 2018;8(1):102.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"5505_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-020-0628-2","volume":"10","author":"J Demiselle","year":"2020","unstructured":"Demiselle J, Fage N, Radermacher P, Asfar P. Vasopressin and its analogues in shock states: a review. Ann Intensive Care. 2020;10(1):9.","journal-title":"Ann Intensive Care"},{"issue":"11","key":"5505_CR19","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","volume":"45","author":"JA Russell","year":"2019","unstructured":"Russell JA. Vasopressor therapy in critically ill patients with shock. Intensive Care Med. 2019;45(11):1503\u201317.","journal-title":"Intensive Care Med"},{"issue":"9","key":"5505_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877\u201387.","journal-title":"N Engl J Med"},{"issue":"5","key":"5505_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA. 2016;316(5):509\u201318.","journal-title":"JAMA"},{"issue":"3","key":"5505_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00134-025-07840-1","volume":"51","author":"A Mekontso Dessap","year":"2025","unstructured":"Mekontso Dessap A, AlShamsi F, Belletti A, De Backer D, Delaney A, Moller MH, et al. European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients: part 2-the volume of resuscitation fluids. Intensive Care Med. 2025;51(3):461\u201377.","journal-title":"Intensive Care Med"},{"issue":"9","key":"5505_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018;378(9):809\u201318.","journal-title":"N Engl J Med"},{"issue":"9","key":"5505_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med. 2018;378(9):797\u2013808.","journal-title":"N Engl J Med"},{"issue":"3","key":"5505_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","volume":"37","author":"JA Russell","year":"2009","unstructured":"Russell JA, Walley KR, Gordon AC, Cooper DJ, H\u00e9bert PC, Singer J, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009;37(3):811\u20138.","journal-title":"Crit Care Med"},{"issue":"1","key":"5505_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13613-019-0498-7","volume":"9","author":"TWL Scheeren","year":"2019","unstructured":"Scheeren TWL, Bakker J, De Backer D, Annane D, Asfar P, Boerma EC, et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019;9(1):20.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"5505_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00134-024-07332-8","volume":"50","author":"D De Backer","year":"2024","unstructured":"De Backer D, Hajjar L, Monnet X. Vasoconstriction in septic shock. Intensive Care Med. 2024;50(3):459\u201362.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5505_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","volume":"50","author":"GL Sacha","year":"2022","unstructured":"Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock. Crit Care Med. 2022;50(4):614\u201323.","journal-title":"Crit Care Med"},{"issue":"1","key":"5505_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12879-023-08147-6","volume":"23","author":"J Xu","year":"2023","unstructured":"Xu J, Cai H, Zheng X. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases. BMC Infect Dis. 2023;23(1):199.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"5505_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SHK.0000000000001978","volume":"58","author":"AC Rydz","year":"2022","unstructured":"Rydz AC, Elefritz JL, Conroy M, Disney KA, Miller CJ, Porter K, et al. Early Initiation of Vasopressin Reduces Organ Failure and Mortality in Septic Shock. Shock. 2022;58(4):269\u201374.","journal-title":"Shock"},{"issue":"4","key":"5505_CR31","first-page":"295","volume":"26","author":"KC White","year":"2024","unstructured":"White KC, Costa-Pinto R, Chaba A, McIlroy P, Senthuran S, Luke S, et al. Timing of adjunctive vasopressin initiation for septic shock patients and hospital mortality: A multicentre observational study. Crit Care Resusc. 2024;26(4):295\u2013302.","journal-title":"Crit Care Resusc"},{"issue":"5","key":"5505_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/SHK.0000000000002214","volume":"60","author":"E Ye","year":"2023","unstructured":"Ye E, Ye H, Wang S, Fang X. Initiation Timing of Vasopressor in Patients with Septic Shock: A Systematic Review and Meta-Analysis. Shock. 2023;60(5):627\u201336.","journal-title":"Shock"},{"issue":"1","key":"5505_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13613-025-01428-0","volume":"15","author":"CH Ma","year":"2025","unstructured":"Ma CH, Healy J, Kinteh E, Ma CC, Tzeng CT, Chou EH, et al. Extremely early initiation of vasopressors might not decrease short-term mortality for adults with septic shock: a systematic review and meta-analysis. Ann Intensive Care. 2025;15(1):18.","journal-title":"Ann Intensive Care"},{"key":"5505_CR34","doi-asserted-by":"crossref","unstructured":"Kalimouttou A, Kennedy JN, Feng J, Singh H, Saria S, Angus DC, et al. Optimal Vasopressin Initiation in Septic Shock: The OVISS Reinforcement Learning Study. Jama. 2025.","DOI":"10.1001\/jama.2025.3046"},{"issue":"1","key":"5505_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13054-025-05401-y","volume":"29","author":"KC White","year":"2025","unstructured":"White KC, Costa-Pinto R, Blank S, Whebell S, Quick L, Luke S, et al. Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation. Crit Care. 2025;29(1):188.","journal-title":"Crit Care"},{"issue":"11","key":"5505_CR36","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","volume":"44","author":"ZM Liu","year":"2018","unstructured":"Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018;44(11):1816\u201325.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5505_CR37","first-page":"50","volume":"53","author":"Z Wu","year":"2020","unstructured":"Wu Z, Zhang S, Xu J, Xie J, Huang L, Huang Y, et al. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis Shock. 2020;53(1):50\u20137.","journal-title":"A Meta-Analysis Shock"},{"issue":"1","key":"5505_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13054-018-2034-9","volume":"22","author":"K Jeon","year":"2018","unstructured":"Jeon K, Song JU, Chung CR, Yang JH, Suh GY. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS). Crit Care. 2018;22(1):131.","journal-title":"Crit Care"},{"key":"5505_CR39","doi-asserted-by":"crossref","unstructured":"Mallmann C, Galiotto TMB, de Oliveira MS, Moraes RB. Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial. Med Intensiva (Engl Ed). 2025:502147.","DOI":"10.1016\/j.medine.2025.502147"},{"issue":"4","key":"5505_CR40","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00134-024-07374-y","volume":"50","author":"E Kattan","year":"2024","unstructured":"Kattan E, Ibarra-Estrada M, Jung C. Knowing the ropes of vasopressor dosing: a focus on norepinephrine. Intensive Care Med. 2024;50(4):587\u20139.","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05505-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05505-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05505-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:44:36Z","timestamp":1751528676000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05505-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5505"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05505-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey was endorsed by the European Society of Intensive Care Medicine (ESICM).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"XM received fees for giving lectures from Getinge, Baxter healthcare, BD, Masimo and AOP health. XM received fees for consulting from Getinge and BD. XM received unrestricted research grants from Baxter healthcare and Masimo. MLNGM is Professor of Critical Care Research at the 1\u2009st Department of Anaesthesiology and Intensive Therapy, Medical University of Lublin, Poland. He is co-founder, past-President and current Treasurer of WSACS (The Abdominal Compartment Society,\n                      \n                      ). He is member of the medical advisory Board of Pulsion Medical Systems (now fully part of Getinge group), Sentinel Medical, and Baxter. He consults for BBraun, Becton Dickinson, Fresenius Kabi, Lexin, Maltron, Spiegelberg, Medtronic, MedCaptain, and Holtech Medical, and received speaker's fees from PeerVoice, WICCEM and Fresenius-Kabi. He holds stock options for Sentinel, Serenno and Potrero. He is co-founder and President of the International Fluid Academy (IFA). The IFA (\n                      \n                      ) is integrated within the not-for-profit charitable organization iMERiT, International Medical Education and Research Initiative, under Belgian law. MC has received speaker\u2019s and advisory board honoraria from Edwards Lifesciences, AOP Health, Laboratorie Agguetant and Philips Healthcare. The other authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}